MAM
CABA icon

Marquette Asset Management’s Cabaletta Bio CABA Stock Holding History

Marquette Asset Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,539
Closed -$125K – 216
2022
Q4 		$125K Buy
+13,539
New +$49.3K 0.04% 98

Other funds holding CABA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Marquette Asset Management's CABA Position: Q1 2023 in Review

Marquette Asset Management sold out of Cabaletta Bio (CABA) in Q1 2023, closing a stake of 13,539 shares — an estimated $125K sold.

Marquette Asset Management first reported a position in CABA in Q4 2022 and held it in 1 quarter. The position peaked at $125K in Q4 2022. 71 funds tracked by Wall St. Rank hold CABA as of Q1 2023.

  • Marquette Asset Management reported no remaining Cabaletta Bio position as of Q1 2023 after selling out during the quarter.
  • Marquette Asset Management sold 13,539 Cabaletta Bio shares in Q1 2023, an estimated $125K.
  • Marquette Asset Management first reported a position in Cabaletta Bio in Q4 2022 and held it in 1 quarter.
  • Marquette Asset Management's Cabaletta Bio position peaked at $125K in Q4 2022.
  • 71 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2023.

Based on Marquette Asset Management's 13F filing for Q1 2023, filed 1 May 2023.